Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RSV/IAV-IN-3 (compound 14'i) is a dual inhibitor of respiratory syncytial virus (RSV) (EC50: 2.92 μM) and influenza A virus (IAV) (EC50: 1.90 μM). RSV/IAV-IN-3 significantly inhibited luciferase activity in a dose-dependent manner (EC50: 3.89 μM). RSV/IAV-IN-3 inhibited IAV infection and RdRp activity, and inhibited IAV and RSV replication during the post-entry phase.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | RSV/IAV-IN-3 (compound 14'i) is a dual inhibitor of respiratory syncytial virus (RSV) (EC50: 2.92 μM) and influenza A virus (IAV) (EC50: 1.90 μM). RSV/IAV-IN-3 significantly inhibited luciferase activity in a dose-dependent manner (EC50: 3.89 μM). RSV/IAV-IN-3 inhibited IAV infection and RdRp activity, and inhibited IAV and RSV replication during the post-entry phase. |
Molecular Weight | 435.33 |
Formula | C19H19BrN2O3S |
CAS No. | 2395007-81-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RSV/IAV-IN-3 2395007-81-3 inhibitor inhibit